Jubilant Pharmova Limited (NSE: JUBLPHARMA) reported a Revenue from Operations of ₹1,533.22 Crores, a boost of 18% growth from the previous year. The Net Loss for the business is ₹16.04 Crore from the profit of ₹50.80 Crore year on year. Earnings per Share is -₹0.98 for this quarter.
Jubilant Pharmova Limited Q3 FY23; Revenue Increased By 18%
Tags: pharmaceuticals
Related Post
- Tata Technologies Ltd Q4 FY24 Earnings Conference Call Insights
Key highlights from Tata Technologies Ltd (TATATECH) Q4 FY24 Earnings Concall Revenue Growth and Deal…
-
Sona BLW Precision Forgings Limited Q4 FY24 Earnings Conference Call Insights
Key highlights from Sona BLW Precision Forgings Limited (SONACOMS) Q4 FY24 Earnings Concall BEV Revenue…
-
Raymond Ltd Q4FY24; 17% rise in Profits
Raymond Limited incorporated in 1925 is a diversified group with interests in Textile & Apparel…